{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:56:28Z","timestamp":1773316588844,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2019ZX09201001-003"],"award-info":[{"award-number":["2019ZX09201001-003"]}],"id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["CIFMS 2016-I2M-1-011"],"award-info":[{"award-number":["CIFMS 2016-I2M-1-011"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235483","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:25:22Z","timestamp":1595438722000},"page":"e0235483","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study"],"prefix":"10.1371","volume":"15","author":[{"given":"Huiyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1736-6749","authenticated-orcid":true,"given":"Guoning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-1132","authenticated-orcid":true,"given":"Juxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"issue":"21","key":"pone.0235483.ref001","first-page":"1","article-title":"Pneumocystis pneumonia\u2014Los Angeles","volume":"30","author":"MS Gottlieb","year":"1981","journal-title":"Morb Mortal Weekly Rep"},{"key":"pone.0235483.ref002","unstructured":"UNAIDS. Global HIV & AIDS statistics\u20142019 fact sheet. 2020; 3: 15. https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"issue":"2","key":"pone.0235483.ref003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/jm900492g","article-title":"Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?","volume":"53","author":"Y Mehellou","year":"2010","journal-title":"J Med Chem"},{"issue":"11","key":"pone.0235483.ref004","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV\/AIDS","volume":"59","author":"AK Ghosh","year":"2016","journal-title":"J Med Chem"},{"issue":"12","key":"pone.0235483.ref005","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/acsmedchemlett.7b00386","article-title":"Design and synthesis of piperazine sulfonamide cores leading to highly potent HIV-1 protease inhibitors","volume":"8","author":"CJ Bungard","year":"2017","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"pone.0235483.ref006","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/13543784.2016.1212837","article-title":"Investigational protease inhibitors as antiretroviral therapies","volume":"25","author":"NM Midde","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"issue":"21","key":"pone.0235483.ref007","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1021\/acs.jmedchem.8b01227","article-title":"Design and synthesis of potent HIV-1 protease inhibitors containing bicyclic oxazolidinone scaffold as the P2 ligands: Structure\u2013activity studies and biological and X-ray structural studies","volume":"61","author":"AK Ghosh","year":"2018","journal-title":"J Med Chem"},{"issue":"18","key":"pone.0235483.ref008","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.bmcl.2019.08.006","article-title":"Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design synthesis and biological evaluation","volume":"29","author":"AK Ghosh","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"pone.0235483.ref009","doi-asserted-by":"crossref","first-page":"e02060","DOI":"10.1128\/AAC.02060-17","article-title":"GRL-079 a novel HIV-1 protease inhibitor is extremely potent against multidrug-resistant HIV-1 variants and has a high genetic barrier against the emergence of resistant variants","volume":"62","author":"NS Delino","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"pone.0235483.ref010","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/acs.jmedchem.9b00838","article-title":"HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2\u2032 Ligands To Optimize Hydrogen Bonding in the Substrate Envelope","volume":"62","author":"LN Rusere","year":"2019","journal-title":"J Med Chem"},{"issue":"12","key":"pone.0235483.ref011","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bmcl.2019.03.049","article-title":"Synthesis and biological evaluation of new HIV-1 protease inhibitors with purine bases as P2-ligands","volume":"29","author":"M Zhu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0235483.ref012","doi-asserted-by":"crossref","first-page":"111866","DOI":"10.1016\/j.ejmech.2019.111866","article-title":"Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants","volume":"185","author":"M Zhu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"pone.0235483.ref013","doi-asserted-by":"crossref","first-page":"111900","DOI":"10.1016\/j.ejmech.2019.111900","article-title":"Rational design and Structure\u2212 Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase","volume":"186","author":"M Zhu","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"9","key":"pone.0235483.ref014","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.bmcl.2015.03.047","article-title":"Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands","volume":"25","author":"ZH Yang","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0235483.ref015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2017.05.024","article-title":"Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2\u2212 ligand: Structure\u2212 activity studies and biological evaluation","volume":"137","author":"X Bai","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"7","key":"pone.0235483.ref016","doi-asserted-by":"crossref","first-page":"127019","DOI":"10.1016\/j.bmcl.2020.127019","article-title":"Design synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1\u2032 ligand","volume":"30","author":"Y Dou","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"pone.0235483.ref017","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1747-0285.2010.00995.x","article-title":"Design Biologic Evaluation and SAR of Novel Pseudo-peptide Incorporating Benzheterocycles as HIV-1 Protease Inhibitors","volume":"76","author":"M He","year":"2010","journal-title":"Chem Biol Drug Des"},{"issue":"5","key":"pone.0235483.ref018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/1062936X.2018.1447511","article-title":"Structural exploration of hydroxyethylamines as HIV-1 protease inhibitors: new features identified","volume":"29","author":"SA Amin","year":"2018","journal-title":"SAR QSAR Environ Res"},{"key":"pone.0235483.ref019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/B978-0-12-397176-0.00013-3","volume-title":"Introduction to biological and small molecule drug research and development: theory and case studies","author":"AK Ghosh","year":"2013"},{"issue":"13","key":"pone.0235483.ref020","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/j.bmcl.2013.04.080","article-title":"Optimization of novel nipecotic bis (amide) inhibitors of the Rho\/MKL1\/SRF transcriptional pathway as potential anti-metastasis agents","volume":"23","author":"JL Bell","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0235483.ref021","unstructured":"Biofocus PLC Ward T Crossley R. WO2004\/58259 2004 A1."},{"issue":"17","key":"pone.0235483.ref022","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1021\/jm060561m","article-title":"Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance","volume":"49","author":"AK Ghosh","year":"2006","journal-title":"J Med Chem"},{"issue":"4945","key":"pone.0235483.ref023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.2106161","article-title":"Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer","volume":"247","author":"ED Matayoshi","year":"1990","journal-title":"Science"},{"issue":"5","key":"pone.0235483.ref024","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/jm001064n","article-title":"Design synthesis and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity","volume":"44","author":"SJ Gregson","year":"2001","journal-title":"J Med Chem"},{"issue":"12","key":"pone.0235483.ref025","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.bmcl.2011.04.070","article-title":"Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands","volume":"21","author":"BL Gao","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"pone.0235483.ref026","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/jm300238h","article-title":"Design synthesis and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance","volume":"55","author":"MK Parai","year":"2012","journal-title":"J Med Chem"},{"issue":"1","key":"pone.0235483.ref027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmb.2006.08.007","article-title":"Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114","volume":"363","author":"AY Kovalevsky","year":"2006","journal-title":"J Mol Biol"},{"issue":"13","key":"pone.0235483.ref028","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1021\/acs.jmedchem.5b00676","article-title":"Structure-Based Design of Potent HIV-1 Protease Inhibitors with Modified P1-Biphenyl Ligands: Synthesis Biological Evaluation and Enzyme\u2013Inhibitor X-ray Structural Studies","volume":"58","author":"AK Ghosh","year":"2015","journal-title":"J Med Chem"},{"issue":"13","key":"pone.0235483.ref029","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/jm900303m","article-title":"Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1\u2032-ligands to enhance backbone-binding interactions with protease: Synthesis biological evaluation and protein\u2212 ligand x-ray studies","volume":"52","author":"AK Ghosh","year":"2009","journal-title":"J Med Chem"},{"key":"pone.0235483.ref030","doi-asserted-by":"crossref","first-page":"e28020","DOI":"10.7554\/eLife.28020","article-title":"A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency","volume":"6","author":"M Aoki","year":"2017","journal-title":"eLife"},{"issue":"8","key":"pone.0235483.ref031","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cmdc.201700824","article-title":"Design of Highly Potent Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants","volume":"13","author":"AK Ghosh","year":"2018","journal-title":"ChemMedChem"},{"issue":"2","key":"pone.0235483.ref032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"H Tominaga","year":"1999","journal-title":"Anal Commun"},{"issue":"2","key":"pone.0235483.ref033","doi-asserted-by":"crossref","first-page":"e02425","DOI":"10.1128\/mBio.02425-17","article-title":"Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance","volume":"9","author":"M Aoki","year":"2018","journal-title":"mBio"},{"issue":"3","key":"pone.0235483.ref034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.antiviral.2008.12.004","article-title":"High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay","volume":"81","author":"JM Garcia","year":"2009","journal-title":"Antiviral Res"},{"issue":"18","key":"pone.0235483.ref035","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.tet.2014.03.038","article-title":"Structural optimization of cyclic sulfonamide based novel HIV-1 protease inhibitors to picomolar affinities guided by X-ray crystallographic analysis","volume":"70","author":"AK Ganguly","year":"2014","journal-title":"Tetrahedron"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:26:17Z","timestamp":1595438777000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235483"}},"subtitle":[],"editor":[{"given":"A","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235483","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]}}}